Viewing Study NCT01873703


Ignite Creation Date: 2025-12-24 @ 7:24 PM
Ignite Modification Date: 2026-02-25 @ 4:57 PM
Study NCT ID: NCT01873703
Status: COMPLETED
Last Update Posted: 2018-09-13
First Post: 2013-05-22
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 2 Study of Pracinostat With Azacitidine in Patients With Previously Untreated Myelodysplastic Syndrome
Sponsor: Helsinn Healthcare SA
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Myelodysplastic Syndrome View
Keywords:

Keywords

Keyword Brief Keyword Text View
None MDS View
None High risk myelodysplastic syndrome View
None Intermediate-2 Myelodysplastic syndrome View
None Untreated View